Pfizer CentreOne

Articles

Assuring drug substance and product supply chains to support worldwide delivery of Sobi’s life-saving biologic 

Sterile injectables (SI) and complex biologics can be leveraged from both a technical and business development standpoint. Pfizer CentreOne® is an altogether different global contract development and manufacturing organization (CDMO), and a leading supplier of specialty APIs and intermediates.

Pfizer CentreOne Perspectives: Sterile Injectable Capabilities and Responding to Emerging Trends

Podcasts

In this podcast, hear from our global experts Martin Gonzalez, PHD and Katharine Sparhawk as they share exclusive details of Pfizer CentreOne’s sterile injectable capabilities from both a technical expertise and business development point of view. Our experts will explore key topics including emerging sterile injectable trends, the company’s approach to flexibility in capacity planning and emerging trends that are shaping the development of complex biologics like ADCs.

Pfizer CentreOne Perspectives: From Exploring Sterile Injectable Capabilities to Responding to Emerging Trends

In this application note, Pfizer CentreOne examines key considerations for the development and manufacturing of your unique sterile injectable.

Supporting the unique needs of your sterile injectable with exact SI-ence (Dec 2023)

Developing and manufacturing highly potent oral solid dose drugs to respond to increasing demand in the industry requires specialized procedures and expertise.